Fulcrum Therapeutics (FULC) Total Current Liabilities (2019 - 2025)
Historic Total Current Liabilities for Fulcrum Therapeutics (FULC) over the last 7 years, with Q3 2025 value amounting to $11.6 million.
- Fulcrum Therapeutics' Total Current Liabilities fell 1982.91% to $11.6 million in Q3 2025 from the same period last year, while for Sep 2025 it was $11.6 million, marking a year-over-year decrease of 1982.91%. This contributed to the annual value of $11.0 million for FY2024, which is 1923.95% down from last year.
- According to the latest figures from Q3 2025, Fulcrum Therapeutics' Total Current Liabilities is $11.6 million, which was down 1982.91% from $9.0 million recorded in Q2 2025.
- Over the past 5 years, Fulcrum Therapeutics' Total Current Liabilities peaked at $22.6 million during Q1 2021, and registered a low of $8.1 million during Q1 2025.
- Moreover, its 5-year median value for Total Current Liabilities was $14.5 million (2024), whereas its average is $15.3 million.
- Per our database at Business Quant, Fulcrum Therapeutics' Total Current Liabilities soared by 6144.3% in 2021 and then plummeted by 3307.72% in 2023.
- Quarter analysis of 5 years shows Fulcrum Therapeutics' Total Current Liabilities stood at $19.2 million in 2021, then decreased by 12.89% to $16.7 million in 2022, then dropped by 18.24% to $13.7 million in 2023, then decreased by 19.24% to $11.0 million in 2024, then increased by 5.32% to $11.6 million in 2025.
- Its last three reported values are $11.6 million in Q3 2025, $9.0 million for Q2 2025, and $8.1 million during Q1 2025.